Advanced search

Report side effect

Report a suspected side effect or falsified product to the MHRA Yellow Card scheme.
Go to {yellow_card_logo} site
Trusted Information Creator
Certified November 2025
{arrow_up} Back to top

Sodium Valproate Strandhaven 200 mg/5 ml Oral Solution {equilateral_black_triangle}

Active Ingredient:
sodium valproate
Company:  
Strandhaven Limited t/a Somex Pharma See contact details
ATC code: 
N03AG01
{info_black}
About Medicine
{medical_services}
Prescription only medicine
Healthcare Professionals (SmPC) Patient Leaflet (PIL) Risk Materials Letters to HCPs
{arrow_left}
{arrow_right}

Important information for Healthcare Professionals

{pdf_link}

Valproate DHPC - letter for HCPs UK - PASS Paternal

{healthcare_pro_orange} For Healthcare Professionals

New measures regarding the potential risk of neurodevelopmental disorders in children of fathers treated with valproate in the 3 months prior to conception

You are trying to reach document intended for healthcare professionals only.

Are you a healthcare professional?

Log in or sign up to avoid further verifications.

Strandhaven Limited t/a Somex Pharma
Company image
Address
600 High Road, Seven Kings, Ilford, Essex, IG3 8BS, UK
Telephone
020 8590 9399
Fax
020 8599 4437
Medical Information Direct Line
020 8590 9399
Medical Information Fax
020 8590 9399
Medical Information e-mail
[email protected]
Customer Care direct line
020 8590 9399
Stock Availability
[email protected]
WWW
https://www.somexpharma.co.uk/